Does a $5M to $10M ARR healthtech company need a fractional Chief Revenue Officer in 2027?
Direct Answer
If your healthtech company has crossed $5M ARR but is stuck below $10M, you likely have a revenue problem that a single VP of Sales cannot solve alone. A fractional CRO brings the strategic layer—pricing, channel strategy, buyer journey mapping, and cross-functional alignment—without the $250k-$350k+ cash comp of a full-time CRO. The decision hinges on whether your current leadership can articulate and execute a 12-month revenue plan, or whether you need external expertise to build that plan from scratch.
How to Evaluate If You Need a Fractional CRO
Fractional CRO vs. Full-Time CRO
The Healthtech Context Matters
Healthtech revenue models are unusually complex compared to SaaS in other verticals. You are selling into hospitals, health systems, or large group practices where buying cycles involve compliance, HIPAA reviews, IT security audits, and clinical champions. A fractional CRO who has direct experience in healthcare sales can save you months of trial-and-error. Without that domain knowledge, a generalist fractional CRO may struggle to navigate regulatory purchasing processes or understand the difference between selling to a CFO versus a Chief Medical Officer.
Your $5M-$10M ARR stage is the most dangerous. Below $5M, you can often get away with founder-led sales. Above $10M, you usually have enough revenue to justify a full-time CRO. The $5M-$10M band is where companies either build a repeatable sales machine or plateau indefinitely. A fractional CRO can provide the temporary executive bandwidth to build that machine without committing to a permanent hire.
What a Fractional CRO Actually Does at This Stage
A fractional CRO is not a part-time sales rep. They do three things:
- Diagnose the revenue engine — They audit your pipeline, deal stages, pricing, team composition, and buyer feedback. They will tell you why you are stuck, even if the answer is uncomfortable (e.g., "your product is priced wrong for the market" or "your AEs are not qualified to sell at this ACV").
- Build the 12-month revenue plan — This includes target ICP refinement, channel strategy (direct sales vs. partnerships vs. marketplace), hiring plan, and revenue targets by quarter. They will also define the metrics that matter: pipeline velocity, win rate by segment, average deal size, and customer acquisition cost.
- Execute alongside your team — Depending on the engagement, they may manage your VP of Sales directly, coach AEs on deals, negotiate key contracts, or help close your top 5-10 opportunities. They do not replace your sales team; they make your sales team more effective.
The Cost Reality
Fractional CRO pricing varies by scope, geography, and the executive's track record. Here is an honest range based on market norms:
- Advisory only (2-4 days per month, strategy and reviews): $8,000–$12,000/month
- Hands-on management (6-8 days per month, including team management and deal coaching): $12,000–$18,000/month
- Full-time equivalent (10+ days per month, essentially a part-time CRO): $18,000–$25,000/month
Some fractional CROs will accept a reduced cash rate plus equity (typically 0.5%–1.5% of the company, vesting over 2-3 years). This is common in early-stage healthtech where cash is tight. Be aware that fractional CROs who take equity are investing in your outcome—they will expect a board-level view and may push for changes that a pure consultant would not.
When You Should NOT Hire a Fractional CRO
Honesty demands the flip side. A fractional CRO is not the right move if:
- Your revenue problem is actually a product problem. If customers aren't buying because the product is incomplete, buggy, or mispriced, no amount of sales leadership will fix that. Fix the product first.
- You have no sales team to manage. If you are still founder-led with zero AEs, a fractional CRO may be overkill. Hire a VP of Sales or a senior AE first.
- You cannot commit to the changes they recommend. Fractional CROs are expensive because they bring hard truths. If you will ignore their pricing, team, or process recommendations, you are wasting money.
- Your ARR is below $3M. At that stage, the founder should still own revenue. A fractional CRO is premature unless you have a very specific channel or partnership problem.
How the Engagement Typically Works
A standard fractional CRO engagement at $5M-$10M ARR healthtech follows this arc:
The first 30 days are diagnostic. The CRO will interview your team, review your CRM data (Salesforce or HubSpot), listen to Gong recordings, and shadow your sales calls. They will deliver a written assessment with specific recommendations. From month two onward, they execute alongside you.
The Hiring and Vetting Process
Finding a good fractional CRO for healthtech requires specific vetting. Look for:
- Proven experience in healthcare or regulated B2B sales. Ask for examples of navigating HIPAA compliance in the sales process, or selling to hospital procurement teams.
- A track record of scaling companies from $5M to $15M+ ARR. Not just "I was a CRO at a $50M company." You need someone who has done the exact stage you are in.
- References from founders, not just board members. Founders will give you the real story about whether the CRO was hands-on or just strategic.
- Tool proficiency. They should be comfortable with Salesforce or HubSpot, Gong or Chorus, and Clari or similar forecasting tools. If they cannot navigate your tech stack, they will waste time.
The Alternative: Full-Time VP of Sales
Some founders argue that a full-time VP of Sales is cheaper than a fractional CRO. That is true on a per-month basis for a junior VP ($15k-$20k/month cash), but false when you factor in the cost of a bad hire. A fractional CRO is temporary and low-risk—you can terminate the contract with 30 days notice. A full-time VP of Sales who fails will cost you 6-12 months of salary, severance, and lost pipeline momentum.
FAQ
What is the typical contract length for a fractional CRO? Most engagements run 3 to 12 months, with a 30-day termination clause. Some companies extend to 18 months if they are not ready for a full-time hire.
Can a fractional CRO work remotely for a healthtech company? Yes. Most fractional CROs work remote or hybrid. They will travel for key meetings (board presentations, quarterly reviews, major deal closes) but the day-to-day work is done via video calls, Slack, and CRM.
Will a fractional CRO replace my current VP of Sales? Not necessarily. They often work *with* the VP of Sales, providing strategic direction and coaching. If the VP of Sales is underperforming, the fractional CRO may recommend a replacement as part of their assessment.
How do I measure the ROI of a fractional CRO? Track three metrics before and after: pipeline velocity (time from first touch to close), win rate (percentage of qualified opportunities that close), and average deal size. If these improve by 20%+ within 6 months, the engagement is working.
Do fractional CROs take board seats? Not typically. They are advisors or interim executives, not board members. Some may attend board meetings to present revenue updates, but they do not hold a fiduciary role.
What happens after the fractional CRO engagement ends? You either hire a full-time CRO (using the fractional CRO's playbook) or your internal team takes over with the new processes. Some companies re-engage the fractional CRO quarterly for check-ins.
Sources
- Pavilion: Community for Revenue Leaders
- RevOps Co-op: Revenue Operations Best Practices
- Harvard Business Review: Sales Strategy Articles
- First Round Review: Revenue Leadership Insights
- SaaStr: SaaS Revenue and Go-to-Market Advice
- LinkedIn: Fractional Executive Network
---
People also search for: fractional chief revenue officer · hire a fractional chief revenue officer · fractional chief revenue officer near me · fractional chief revenue officer cost